U.Va. embarks ondiabetes research
By Cait Speaker | October 16, 2007In hopes of treating children suffering from Type 1 diabetes and preventing future cases, the University signed a multi-million dollar contract for international genetic research of the disease. Using the facilities provided by Illumina, Inc., a developer of next-generation life-science tools and genetic analysis, the University is working with the National Institute of Diabetes and Digestive and Kidney Diseases to research the role of genetics and environmental concerns in Type 1 diabetes, Illumina public relations manager Maurissa Bornstein said. "Because it is a disease that is caused by both genetics and environments it can be untangled, and we can find different correlations between gene expression and environmental influences," said Stephen Rich, head of the Type 1 Diabetes Genetics Consortium and University professor. In order to research different environments, researchers took data samples from children around the world, NIDDK Program Director Beena Akolkar said. According to Akolkar, researchers recruited more than 800 affected children as well as their diabetes-free siblings, who have a similar genetic expressions, to give samples which Illumina is now analyzing to investigate the antibodies in the blood. "It is truly an international effort," Rich said.


